Annual Accounts Payable
$14.22 M
+$2.23 M+18.58%
December 31, 2024
Summary
- As of March 10, 2025, ARQT annual accounts payable is $14.22 million, with the most recent change of +$2.23 million (+18.58%) on December 31, 2024.
- During the last 3 years, ARQT annual accounts payable has risen by +$6.87 million (+93.39%).
- ARQT annual accounts payable is now at all-time high.
Performance
ARQT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$14.22 M
-$5.11 M-26.42%
December 31, 2024
Summary
- As of March 10, 2025, ARQT quarterly accounts payable is $14.22 million, with the most recent change of -$5.11 million (-26.42%) on December 31, 2024.
- Over the past year, ARQT quarterly accounts payable has stayed the same.
- ARQT quarterly accounts payable is now -26.42% below its all-time high of $19.32 million, reached on September 30, 2024.
Performance
ARQT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ARQT Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +18.6% | 0.0% |
3 y3 years | +93.4% | +7.9% |
5 y5 years | +912.1% | +7.9% |
ARQT Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +93.4% | -26.4% | +93.4% |
5 y | 5-year | at high | +912.1% | -26.4% | +912.1% |
alltime | all time | at high | +2548.0% | -26.4% | +912.1% |
Arcutis Biotherapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $14.22 M(+18.6%) | $14.22 M(-26.4%) |
Sep 2024 | - | $19.32 M(+143.3%) |
Jun 2024 | - | $7.94 M(-38.8%) |
Mar 2024 | - | $12.97 M(+8.1%) |
Dec 2023 | $11.99 M(+35.9%) | $11.99 M(-9.0%) |
Sep 2023 | - | $13.18 M(-23.2%) |
Jun 2023 | - | $17.16 M(+37.4%) |
Mar 2023 | - | $12.48 M(+41.4%) |
Dec 2022 | $8.83 M(+20.0%) | $8.83 M(+1.9%) |
Sep 2022 | - | $8.67 M(+2.7%) |
Jun 2022 | - | $8.44 M(-32.3%) |
Mar 2022 | - | $12.47 M(+69.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $7.35 M(+3.0%) | $7.35 M(+51.0%) |
Sep 2021 | - | $4.87 M(+82.0%) |
Jun 2021 | - | $2.68 M(-14.9%) |
Mar 2021 | - | $3.15 M(-55.9%) |
Dec 2020 | $7.14 M(+408.2%) | $7.14 M(+41.7%) |
Sep 2020 | - | $5.04 M(-38.9%) |
Jun 2020 | - | $8.25 M(+73.4%) |
Mar 2020 | - | $4.76 M(+238.7%) |
Dec 2019 | $1.41 M(-22.0%) | $1.41 M(-55.5%) |
Sep 2019 | - | $3.16 M(+75.4%) |
Dec 2018 | $1.80 M(+235.4%) | $1.80 M |
Dec 2017 | $537.00 K | - |
FAQ
- What is Arcutis Biotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual accounts payable year-on-year change?
- What is Arcutis Biotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly accounts payable year-on-year change?
What is Arcutis Biotherapeutics annual accounts payable?
The current annual accounts payable of ARQT is $14.22 M
What is the all time high annual accounts payable for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual accounts payable is $14.22 M
What is Arcutis Biotherapeutics annual accounts payable year-on-year change?
Over the past year, ARQT annual accounts payable has changed by +$2.23 M (+18.58%)
What is Arcutis Biotherapeutics quarterly accounts payable?
The current quarterly accounts payable of ARQT is $14.22 M
What is the all time high quarterly accounts payable for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly accounts payable is $19.32 M
What is Arcutis Biotherapeutics quarterly accounts payable year-on-year change?
Over the past year, ARQT quarterly accounts payable has changed by $0.00 (0.00%)